Pathophysiology of aortocoronary saphenous vein bypass graft disease

Asian Cardiovascular and Thoracic Annals

Volumn 16, Issue 4, 2008, Pages 331-336

  Hassantash, Seyed Ahmad ^a   Bikdeli, Behnood ^a   Kalantarian, Shadi ^a   Sadeghian, Maryam ^a   Afhar, Haleh ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ANGINA PECTORIS; ARTERY INTIMA PROLIFERATION; ATHEROMA; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CLINICAL EFFECTIVENESS; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DYSLIPIDEMIA; GRAFT FAILURE; GRAFT OCCLUSION; GRAFT PATENCY; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERTENSION; MEDICAL DECISION MAKING; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; REOPERATION; REVIEW; RISK FACTOR; SAPHENOUS VEIN GRAFT; SMOKING; SURGICAL TECHNIQUE; VEIN GRAFT DISEASE; VEIN THROMBOSIS;

EID: 52649173954     PISSN: 02184923     EISSN: None     Source Type: Journal    
DOI: 10.1177/021849230801600418     Document Type: Review

References (80)

1. Hlatky MA, Rogers WJ, Johnstone I, Boothroyd D, Brooks MM, Pitt B, et al. Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N Engl J Med 1997;336:92-9.
2. Niles NW, McGrath PD, Malenka D, Quinton H, Wennberg D, Shubrooks SJ, et al. Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous coronary revascularization: results of a large regional prospective study. Northern New England Cardiovascular Study Group. J Am Coll Cardiol 2001;37:1008-15.
3. Rodriguez A, Bernardi V, Navia J, Baldi J, Grinfeld L, Martinez J, et al. Argentine randomized study: coronary angioplasty with stenting versus coronary artery bypass surgery in patients with multiple-vessel disease (ERACI II): 30-day and one-year follow-up results. ERACI II Investigators. J Am Coll Cardiol 2001;37:51-8.
4. Hannan EL, Racz MJ, McCallister BD, Ryan TJ, Arani DT, Isom OW, et al. A comparison of three-year survival after coronary artery bypass graft surgery and percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1999;33:63-72.
5. Reul RM. Will drug-eluting stents replace coronary artery bypass surgery? Tex Heart Inst J 2005;32:323-30.
6. Ong AT, Serruys PW. Drug-eluting stents: current issues. Tex Heart Inst J 2005;32:372-7.
7. Serruys PW, Kutryk MJ, Ong AT. Coronary-artery stents [Review]. N Engl J Med 2006;354:483-95.
8. Bulkley BH, Hutchins GM. Pathology of coronary artery bypass graft surgery. Arch Pathol Lab Med 1978;102:273-80.
9. Yusuf S, Zucker D, Peduzzi P, Fisher LD, Takaro T, Kennedy JW, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994;344:563-70.
10. Davis KB, Chaitman B, Ryan T, Bittner V, Kennedy JW. Comparison of 15-year survival for men and women after initial medical or surgical treatment for coronary artery disease: a CASS registry study. Coronary Artery Surgery Study. J Am Coll Cardiol 1995;25:1000-9.
11. Tsui JC, Dashwood MR. Recent strategies to reduce vein graft occlusion: a need to limit the effect of vascular damage [Review]. Eur J Vasc Endovasc Surg 2002;23:202-8.
12. Nwasokwa ON. Coronary artery bypass graft disease [Review]. Ann Intern Med 1995;123:528-45.
13. Muneretto C, Bisleri G, Negri A, Manfredi J, Metra M, Nodari S, et al. Total arterial myocardial revascularization with composite grafts improves results of coronary surgery in elderly: a prospective randomized comparison with conventional coronary artery bypass surgery. Circulation 2003;108(Suppl II):29-33.
14. Dilley RJ, McGeachie JK, Prendergast FJ. A review of the histologic changes in vein-to-artery grafts, with particular reference to intimal hyperplasia [Review]. Arch Surg 1988;123:691-6.
15. Woodside KJ, Naoum JJ, Torry RJ, Xue XY, Burke AS, Levine L, et al. Altered expression of vascular endothelial growth factor and its receptor in normal saphenous vein and in arterialized and stenotic vein grafts. Am J Surg 2003;186:561-8.
16. Kanellaki-Kyparissi M, Kouzi-Koliakou K, Marinov G, Knyazev V. Histological study of arterial and venous grafts before their use in aortocoronary bypass surgery. Hellenic J Cardiol 2005;46:21-30.
17. Szilagyi DE, Elliot JP, Hageman JH, Smith RF, Dall'olmo CA. Biologic fate of autogenous vein implants as arterial substitutes: clinical, angiographic and histopathologic observations in femoro-popliteal operations for atherosclerosis. Ann Surg 1973;178:232-46.
18. Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition and prevention. Circulation 1998;97:916-31.
19. Waller BF, Roberts WC. Remnant saphenous veins after aortocoronary bypass grafting: analysis of 3,394 centimeters of unused vein from 402 patients. Am J Cardiol 1985;55:65-71.
20. Davies MG, Hagen PO. Structural and functional consequences of bypass grafting with autologous vein [Review]. Cryobiology 1994;31:63-70.
21. Johnson JL, van Eys GJ, Angelini GD, George SJ. Injury induces dedifferentiation of smooth muscle cells and increased matrix-degrading metalloproteinase activity in human saphenous vein. Arterioscler Thromb Vasc Biol 2001;21:1146-51.
22. He GW. Vascular endothelial function related to cardiac surgery. Asian Cardiovasc Thorac Ann 2004; 12:1-2.
23. Shi Y, O'Brien JE Jr, Mannion JD, Morrison RC, Chung W, Fard A, et al. Remodeling of autologous saphenous vein grafts. The role of perivascular myofibroblasts. Circulation 1997;95:2684-93.
24. Mills NL, Everson CT. Vein graft failure [Review]. Curr Opin Cardiol 1995;10:562-8.
25. Angelini GD, Passani SL, Breckenridge IM, Newby AC. Nature and pressure dependence of damage induced by distension of human saphenous vein coronary artery bypass grafts. Cardiovasc Res 1987;21:902-7.
26. Bush HL Jr, Jakubowski JA, Curl GR, Deykin D, Nabseth DC. The natural history of endothelial structure and function in arterialized vein grafts. J Vasc Surg 1986;3:204-15.
27. Thatte HS, Khuri SF. The coronary artery bypass conduit: I. Intraoperative endothelial injury and its implication on graft patency. Ann Thorac Surg 2001;72:S2245-52.
28. Ohta O, Kusaba A. Development of vasa vasorum in the arterially implanted autovein bypass graft and its anastomosis in the dog. Int Angiol 1997; 16:197-203.
29. Rao GN, Berk BC. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ Res 1992;70:593-9.
30. Zou Y, Dietrich H, Hu Y, Metzler B, Wick G, Xu Q. Mouse model of venous bypass graft arteriosclerosis. Am J Pathol 1998;153:1301-10.
31. Barboriak JJ, Pintar K, Van Horn DL, Batayias GE, Korns ME. Pathologic findings in the aortocoronary vein grafts. A scanning electron microscope study. Atherosclerosis 1978;29:69-80.
32. Vlodaver Z, Edwards JE. Pathologic changes in aortic-coronary arterial saphenous vein grafts. Circulation 1971;44:719-28.
33. Bourassa MG, Campeau L, Lespérance J, Grondin CM. Changes in grafts and coronary arteries after saphenous vein aortocoronary bypass surgery: results at repeat angiography. Circulation 1982;65:90-7.
34. Rosenfeldt FL, He GW, Buxton BF, Angus JA. Pharmacology of coronary artery bypass grafts [Review]. Ann Thorac Surg 1999;67:878-88.
35. Peykar S, Angiolillo DJ, Bass TA, Costa MA. Saphenous vein graft disease. Minerva Cardioangiol 2004;52:379-90.
36. Domanski MJ, Borkowf CB, Campeau L, Knatterud GL, White C, Hoogwerf B, et al. Prognostic factors for atherosclerosis progression in saphenous vein grafts: the postcoronary artery bypass graft (Post-CABG) trial. Post-CABG Trial Investigators. J Am Coll Cardiol 2000;36:1877-83.
37. Mehta D, Izzat MB, Bryan AJ, Angelini GD, Towards the prevention of vein graft failure [Review]. Int J Cardiol 1997;62(Suppl 1):S55-63.
38. Brody JI, Pickering NJ, Capuzzi DM, Fink GB, Can CA, Gomez F. Interleukin-1 alpha as a factor in occlusive vascular disease. Am J Clin Pathol 1992;97:8-13.
39. Schwartz SM, deBlois D, O'Brien ER. The intima. Soil for atherosclerosis and restenosis. Circ Res 1995;77:445-65.
40. Zhang L, Peppel K, Brian L, Chien L, Freedman NJ. Vein graft neointimal hyperplasia is exacerbated by tumor necrosis factor receptor-1 signaling in graft-intrinsic cells. Arterioscler Thromb Vasc Biol 2004;24:2277-83.
41. Leask RL, Butany J, Johnston KW, Ethier CR, Ojha M. Human saphenous vein coronary artery bypass graft morphology, geometry and hemodynamics. Ann Biomed Eng 2005;33:301-9.
42. Butany JW, David TE, Ojha M. Histological and morphometric analyses of early and late aortocoronary vein grafts and distal anastomoses. Can J Cardiol 1998;14:671-7.
43. Hilker M, Tellmann G, Buerke M, Gloger K, Moersig W, Oelert H, et al. Proliferative activity in stenotic human aortocoronary bypass grafts. Cardiovasc Pathol 2002;11:284-90.
44. Shi Y, O'Brien JE, Fard A, Mannion JD, Wang D, Zalewski A. Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation 1996;94:1655-64.
45. Kockx MM, Cambier BA, Bortier HE, De Meyer GF, Declercq SC, van Cauwelaert PA, et al. Foam cell replication and smooth muscle cell apoptosis in human saphenous vein grafts. Histopathology 1994;25:365-71.
46. Dietrich H, Hu Y, Zou Y, Huemer U, Metzler B, Li C, et al. Rapid development of vein graft atheroma in ApoE-deficient mice. Am J Pathol 2000;157:659-69.
47. Amano J, Suzuki A, Sunamori M, Tsukada T, Numano F. Cytokinetic study of aortocoronary bypass vein grafts in place for less than six months. Am J Cardiol 1991;67:1234-6.
48. Lie JT, Lawrie GM, Morris GC Jr. Aortocoronary bypass saphenous vein graft atherosclerosis. Anatomic study of 99 vein grafts from normal and hyperlipoproteinemic patients up to 75 months postoperatively. Am J Cardiol 1977;40:906-14.
49. Atkinson JB, Forman MB, Vaughn WK, Robinowitz M, McAllister HA, Virmani R. Morphologic changes in long-term saphenous vein bypass grafts. Chest 1985;88:341-8.
50. Ratliff NB, Myles JL. Rapidly progressive atherosclerosis in aortocoronary saphenous vein grafts. Possible imumune-mediated disease. Arch Pathol Lab Med 1989;113:772-6.
51. Faria-Neto JR, Chyu KY, Li X, Dimayuga PC, Ferreira C, Yano J, et al. Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null mice. Atherosclerosis 2006;189:83-90.
52. van der Wal AC, Becker AE, Elbers JR, Das PK. An immunocytochemical analysis of rapidly progressive atherosclerosis in human vein grafts. Eur J Cardiothorac Surg 1992;6:469-73.
53. Silva JA, White CJ, Collins TJ, Ramee SR. Morphologic comparison of atherosclerotic lesions in native coronary arteries and saphenous vein graphs with intracoronary angioscopy in patients with unstable angina. Am Heart J 1998;136:156-63.
54. Sisto T, Ylä-Herttuala S, Luoma J, Riekkinen H, Nikkari T. Biochemical composition of human internal mammary artery and saphenous vein. J Vasc Surg 1990;11:418-22.
55. Cherian SM, Bobryshev YV, Inder SJ, Lord RS, Reddi KH, Farnsworth AE, et al. Involvement of dendritic cells in long-term aortocoronary saphenous vein bypass graft failure. Cardiovasc Surg 1999;7:508-18.
56. Sharma R, Li DZ. Role of dendritic cells in atherosclerosis. Asian Cardiovasc Thorac Ann 2006;14:166-9.
57. Merrilees MJ, Beaumont B, Scott LJ. Comparison of deposits of versican, biglycan and decorin in saphenous vein and internal thoracic, radial and coronary arteries: correlation to patency. Coron Artery Dis 2001;12:7-16.
58. van den Boom M, Sarbia M, von Wnuck Lipinski K, Mann P, Meyer-Kirchrath J, Rauch BH, et al. Differential regulation of hyaluronic acid synthase isoforms in human saphenous vein smooth muscle cells: possible implications for vein graft stenosis. Circ Res 2006;98:36-44.
59. Pasterkamp G, Virmani R. The erythrocyte: a new player in atheromatous core formation. Heart 2002;88:115-6.
60. Mautner SL, Mautner GC, Hunsberger SA, Roberts WC. Comparison of composition of atherosclerotic plaques in saphenous veins used as aortocoronary bypass conduits with plaques in native coronary arteries in the same men. Am J Cardiol 1992;70:1380-7.
61. Walts AE, Fishbein MC, Sustaita H, Matloff JM. Ruptured atheromatous plaques in saphenous vein coronary artery bypass grafts: a mechanism of acute, thrombotic, late graft occlusion. Circulation 1982;65:197-201.
62. Castagna MT, Mintz GS, Ohlmann P, Kotani J, Maehara A, Gevorkian N, et al. Incidence, location, magnitude and clinical correlates of saphenous vein graft calcification: an intravascular ultrasound and angiographic study. Circulation 2005;111:1148-52.
63. Lardenoye JH, de Vries MR, Lowik CW, Xu Q, Dhore CR, Cleutjens JP, et al. Accelerated atherosclerosis and calcification in vein grafts: a study in APOE*3 Leiden transgenic mice. Circ Res 2002;91:577-84.
64. Kockx MM, De Meyer GF, Bortier H, de Meyere N, Muhring J, Bakker A, et al. Luminal foam cell accumulation is associated with smooth muscle cell death in the intimal thickening of human saphenous vein grafts. Circulation 1996;94:1255-62.
65. Shafi S, Palinski W, Born GV. Comparison of uptake and degradation of low density lipoproteins by arteries and veins of rabbits. Atherosclerosis 1987;66:131-9.
66. Glasz T, Hortovanyi E, Mozes G, Kiss A, Lotz G, Nagy PK, et al. Chlamydia pneumoniae in coronary bypass grafts of redo patients. The concept of the 'adventitial baseline infection'. Pathol Res Pract 2004;200:609-18.
67. Bartels C, Maass M, Bein G, Malisius R, Brill N, Bechtel JF, et al. Detection of Chlamydia pneumoniae but not cytomegalovirus in occluded saphenous vein coronary artery bypass grafts. Circulation 1999;99:879-82,
68. Solymoss BC, Nadeau P, Millette D, Campeau L. Late thrombosis of saphenous vein coronary bypass grafts related to risk factors. Circulation 1988;78(Suppl I):140-3.
69. Qiao JH, Walts AE, Fishbein MC. The severity of atherosclerosis at sites of plaque rupture with occlusive thrombosis in saphenous vein coronary artery bypass grafts. Am Heart J 1991;122:955-8.
70. Walts AE, Fishbein MC, Matloff JM. Thrombosed, ruptured atheromatous plaques in saphenous vein coronary artery bypass grafts: ten years' experience. Am Heart J 1987;114:718-23.
71. Lee RT, Loree HM, Fishbein MC. High stress regions in saphenous vein bypass graft atherosclerotic lesions. J Am Coll Cardiol 1994;24:1639-44.
72. Pregowski J, Tyczynski P, Mintz GS, Kim SW, Witkowski A, Waksman R, et al. Incidence and clinical correlates of ruptured plaques in saphenous vein grafts: an intravascular ultrasound study. J Am Coll Cardiol 2005;45:1974-9.
73. Campeau L, Enjalbert M, Lesperance J, Bourassa MG, Kwiterovich P Jr, Wacholder S, et al. The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery. N Engl J Med 1984;311:1329-32.
74. Neitzel GF, Barboriak JJ, Pintar K, Qureshi I. Atherosclerosis in aortocoronary bypass grafts. Morphologic study and risk factor analysis 6 to 12 years after surgery. Arteriosclerosis 1986;6:594-600.
75. Senter SR, Nathan S, Gupta A, Klein LW. Clinical and economic outcomes of embolic complications and strategies for distal embolic protection during percutaneous coronary intervention in saphenous vein grafts. J Invasive Cardiol 2006;18:49-53.
76. Giugliano GR, Kuntz RE, Popma JJ, Cutlip DE, Baim DS; Saphenous Vein Graft Angioplasty Free of Emboli Randomized (SAFER) Trial Investigators. Determinants of 30-day adverse events following saphenous vein graft intervention with and without a distal occlusion embolic protection device. Am J Cardiol 2005;95:173-7.
77. Aggarwal A, Terrien EF, Terrien CM Jr. Treatment of totally occluded saphenous vein grafts using self-expanding stents. Coron Artery Dis 2002;13:373-6.
78. Lytle BW, Loop FD, Cosgrove DM, Taylor PC, Goormastic M, Peper W, et al. Fifteen hundred coronary reoperations. Results and determinants of early and late survival. J Thorac Cardiovasc Surg 1987;93:847-59.
79. Depre C, Havaux X, Wijns W. Pathology of restenosis in saphenous bypass grafts after long-term stent implantation. Am J Clin Pathol 1999;110:379-84.
80. Foster ED. Reoperation for coronary artery disease [Review]. Circulation 1985;72(Suppl V):59-64.